Introduction of everolimus in kidney transplant recipients at a late posttransplant stage

This minireview focuses on the current knowledge about the introduction of everolimus (EVL), a mammalian target of rapamycin inhibitor, with calcineurin inhibitor (CNI) elimination or minimization in kidney transplant recipients at a late posttransplant stage. Within, we have summarized two major cl...

Full description

Saved in:
Bibliographic Details
Published in:World J Transplant
Main Authors: Uchida, Junji, Iwai, Tomoaki, Nakatani, Tatsuya
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2018
Subjects:
Minireviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134274/
https://ncbi.nlm.nih.gov/pubmed/30211023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5500/wjt.v8.i5.150
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items